Feedback / Questions
CSM-101 - Casma Therap
https://www.businesswire.com/news/home/20250605004274/en/Casma-Therapeutics-Nominates-CSM-101-as-a-Development-Candidate-for-the-Treatment-of-Rare-and-Common-Forms-of-Parkinsons-Disease
Jun 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next